Skip to main content
×
Home
    • Aa
    • Aa

Antimicrobial Cycling: Lessons Learned From the Aminoglycoside Experience

  • Dale N. Gerding (a1)
Abstract
Abstract

Several discrete strategies have been suggested to prevent or reduce microbial resistance to antimicrobials, including optimal use of the agents (also known as good stewardship); control, removal, or restriction of antimicrobials; use of antimicrobials in combination; and rotational or cyclic use of antimicrobials. The latter strategy is attractive because it periodically removes from the institutional environment certain classes or specific agents that could induce or select resistance. Hospitalwide studies of aminoglycoside substitution employed from the late 1970s through the early 1990s, although not originally intended to test cycling or rotation of aminoglycosides, serendipitously provided data that may be useful in designing future studies. In particular, one 10-year study at the Minneapolis Veterans' Affairs Medical Center (MVAMC) rotated amikacin and gentamicin use over cycles of 12 to 51 months' duration. Significantly reduced resistance to gentamicin was found when amikacin was used, but resistance to gentamicin returned with the first gentamicin recycle. This was followed by reintroduction of amikacin a second time with decreased resistance to gentamicin and, finally, a second reintroduction of gentamicin without resistance to it recurring. Thus, some evidence of proof of principal can be garnered, albeit subject to considerable criticism. Critical examination of the design of the aminoglycoside rotation study and the unforeseen pitfalls is provided as a 13-element guidance list for design of future rotational studies. Rotational usage practices are likely to be most appropriate for drugs active against gram-negative bacilli because of the wide choices available for rotation. Future availability of new agents active against resistant gram-positive organisms will present the opportunity to cycle these agents as vancomycin substitutes. Careful monitoring of clinical outcomes and resistance will be required. Multicenter controlled trials that follow carefully designed protocols are most likely to produce statistically significant and clinically meaningful results.

Copyright
Corresponding author
Medical Service, Lakeside Division, VA Chicago Healthcare System, 333 E Huron St, Chicago, IL 60611
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. DM Shlaes , DN Gerding , JF John Jr, WA Craig , DL Bornstein , RA Duncan , et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals. Infect Control Hosp Epidemiol 1997;18:275291.

2. JE McGowan Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev lnfed Dis 1983;5:10331048.

3. JE McGowan Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478483.

6. CC Carpenter , MA Fischi , SM Hammer , MS Hirsch , DM Jacobsen , DA Katzenstein , et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society—USA panel. JAMA 1997;277:19621969.

7. JW Chow , MJ Fine , DM Shlaes , JP Quinn , DC Hooper , MP Johnson , et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585590.

10. DN Gerding , TA Larson , RA Hughes , M Weiler , C Shanholtzer , LR Peterson . Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimkrob Agents Chemother 1991;35:12841290.

11. RF Betts , WM Valenti , SW Chapman , T Chonmaitree , G Mowrer , P Pincus , et al. Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med 1984;100:219222.

12. DN Gerding , TA Larson . Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Am J Med 1985;79(suppl 1A):17.

13. KH Mayer . Review of epidemic aminoglycoside resistance worldwide. Am J Med 1986;80(suppl 6B):5664.

14. J Davies , P Courvalin . Mechanisms of resistance to aminoglycosides. Am J Med 1977;62:2529.

15. EJ Young , CM Sewell , MA Koza , JE Clarridge . Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 1985;290:223227.

17. DM Bamberger , SL Dahl . Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch Intern Med 1992;152:554557.

18. SL Berk , S Alvarez , G Ortega , A Verghese , SA Holtsclaw-Berk Clinical and microbiological consequences of amikacin use during a 42-month period. Arch Intern Med 1986;146:538541.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Abstract views

Total abstract views: 70 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 30th March 2017. This data will be updated every 24 hours.